ociperlimab,vibostolimab,etigilimab,tiragolumab,belrestotug,Atezolizumab,Bevacizumab,Tocilizumab,TPST-1120,RO7247669,ADG126
beigene,merck,roche,mereo biopharma,mereo biopharma,novartis,iteos,gsk,iteos therapeutics,Adagene,JW Pharma,tempest
['tiragolumab', 'etigilimab', 'ociperlimab', 'eos 448', 'vibostolimab', '$bgne', '$itos', '$mrk', '$gsk', '$nvs', 'gsk', '$mreo', '$rhhby']
#tigit asset that looks active wild-type igg1 $rhhby tiragolumab morpheus-phase ib/ii liver study: great results #asco23 $mreo etigilimab similar to $rhhby $mrk vibostolimab
$itos $gsk eos 448 $bgne $nvs ociperlimab #tigit fc binding asset less active than wild type. 
disclaimer: No investment advice and tweets are my opinion or research that I have  done. Do your own research before investing in stock market.